The Medicare Merit-Based Incentive Payment System (MIPS) will begin on January 1, 2017, and providers across the country are considering which submission mechanism makes most sense for them. Here is a handy reference for you to see which submission mechanisms are available for each performance category, as well as additional details about data submission for the Quality performance category.
Here are some questions to consider as you think about your 2017 submission strategy, which could impact your choice of submission mechanism:
The following table outlines which submission mechanisms can be used for each MIPS reporting categories for those reporting as individuals and those reporting as groups.
|Performance category||Individual reporting data submission mechanisms||Group reporting data submission mechanisms|
|Advancing Care Information||
|Cost (does not contribute to the Composite Performance Score in 2017)||
The following table outlines requirements specific to the Quality performance category for each eligible submission mechanism.
|Submission mechanism||Individual or group reporting||Performance period||Data completeness requirement|
|Part B Claims||Individual MIPS eligible clinicians||A minimum of one continuous 90-day period during CY2017||50% of MIPS eligible clinician’s Medicare Part B patients for the performance period|
Qualified Registry EHR
|Individual MIPS eligible clinicians or groups||A minimum of one continuous 90-day period during CY2017||50% of MIPS eligible clinician’s or groups patients across all payers for the performance period|
|CMS Web Interface||Groups||Jan 1 – Dec 31||Sampling requirements for their Medicare Part B patients|
The following table displays the number of quality measures that can be reported via each eligible submission mechanism. Click here to download the full list of MIPS quality measures, filterable by submission mechanism.
|Submission mechanism||Number of quality measures supported|
|CMS Web Interface||15|
Be the first to know about key PQRS and MACRA information, deadlines, and expert analysis